Novo Nordisk invests $2.3b in France for diabetes, obesity drugs
HQ Team November 23, 2023: Novo Nordisk will invest $2.3 billion to expand production of its weight-loss and diabetes drug in Chartes, France..
Drugs
Health
Pharma
Drugs
Health
Pharma
Lilly to build $2.5b plant in Germany to make diabetes, obesity devices
HQ Team November 18, 2023: Eli Lilly, a US company that forecasts revenue of up to $33.9 billion, plans to build a $2.5.
Drugs
Health
Medical
Role of fructose in obesity, a new perspective
HQ Team October 20, 2023: A new research paper suggests that fructose, a type of sugar, maybe a significant driver of obesity. While.
Drugs
Health
Pharma
Weight-loss drug mimicking exercise may help treat obesity, diabetes
HQ Team October 2, 2023: A drug that mimics the benefits of rigorous exercise has been developed on mice by scientists at the.
Drugs
Health
Pharma
Novo Nordisk’s weight-loss drug Wegovy enters the UK market
HQ Team September 4, 2023: Novo Nordisk, a Danish drugmaker, announced its weight-loss medicine, Wegovy, will be available in the UK in a.
Drugs
Health
Pharma
Obese people have different ‘appetite control centre’ in brain
HQ Team August 9, 2023: The brain’s hypothalamus gland is a relevant factor in obesity and little is known about how this region.
Drugs
Health
Pharma
Eli Lilly to acquire Versanis for $1.9 billion in an obesity drug push
HQ Team July `4, 2023: Eli Lilly and Company will acquire private Versanis for $ 1.93 billion in cash to expand its portfolio.
Drugs
Health
Pharma
WHO advises against use of non-sugar sweeteners for weight loss, NCDs
HQ Team May 15, 2023: The use of non-sugar sweeteners leads to an increased risk of type 2 diabetes, cardiovascular diseases, and mortality.
Drugs
Health
Medical
Obesity drug may be added to WHO list of essential medicines
Obesity is a global concern and the WHO maybe forced add obesity drugs to its essential medicine list